Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
Study Phase: Phase 4
Recruitment Status: Enrolling by invitation
Start Date: March 04, 2018
End Date: July 31, 2023
Inclusion Criteria:
- Youth ages 6-26 years with ADHD as a primary diagnosis
- For former participants of MPH trials to be invited back for PK procedures.
Exclusion Criteria:
- Participants that do not have ADHD as a primary diagnosis
- Participants that do not want, require, or are not healthy enough for medication treatment with MPH for ADHD per the clinical judgment of the treating and study clinicians
- Participants that are smokers or, are pregnant
-
Conditions:
- Attention Deficit Disorder with Hyperactivity